Dissociated response to immune checkpoint inhibition in head and neck squamous cell carcinoma is common and exhibits distinct clinical outcomes.
- DOI
- 10.1158/2767-9764.crc-26-0363
- Published
- 2026 Sep 22
- Container
- Cancer research communications
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/2767-9764.crc-26-0363,
title = {Dissociated response to immune checkpoint inhibition in head and neck squamous cell carcinoma is common and exhibits distinct clinical outcomes.},
author = {Weaver AN and Keysar SB and Dureja A and Chimed TS and Le PN and Nieto C and Alzofon N and Morton JJ and Thomas CM and Lanning RM and Samedi VG and Van Bokhoven A and Jimeno A},
year = {2026},
journal = {Cancer research communications},
doi = {10.1158/2767-9764.crc-26-0363},
url = {https://doi.org/10.1158/2767-9764.crc-26-0363}
}RIS
TY - JOUR TI - Dissociated response to immune checkpoint inhibition in head and neck squamous cell carcinoma is common and exhibits distinct clinical outcomes. AU - Weaver AN AU - Keysar SB AU - Dureja A AU - Chimed TS AU - Le PN AU - Nieto C AU - Alzofon N AU - Morton JJ AU - Thomas CM AU - Lanning RM AU - Samedi VG AU - Van Bokhoven A AU - Jimeno A PY - 2026 JO - Cancer research communications DO - 10.1158/2767-9764.crc-26-0363 UR - https://doi.org/10.1158/2767-9764.crc-26-0363 ER -
APA
AN, W., SB, K., A, D., TS, C., PN, L., C, N., N, A., JJ, M., CM, T., RM, L., VG, S., A, V. B., & A, J. (2026). Dissociated response to immune checkpoint inhibition in head and neck squamous cell carcinoma is common and exhibits distinct clinical outcomes.. Cancer research communications. https://doi.org/10.1158/2767-9764.crc-26-0363
Source records
- pubmed · retrieved 2026-09-25T23:14:08.387Z